OncoSec's Licensing Of CAR-T Tech For Solid Tumors Opens Up A New Door For The Future [Seeking Alpha]
OncoSec Medical Incorporated (ONCS)
Last oncosec medical incorporated earnings: 12/13 05:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
oncosec.com/tag/investor-relations
Company Research
Source: Seeking Alpha
OncoSec's Licensing Of CAR-T Tech For Solid Tumors Opens Up A New Door For The Future Summary OncoSec Medical announced that it has licensed a CAR-T product from Dana-Farber Cancer Institute, specifically from The Marasco Laboratory. The most notable item I can see about the licensed CAR-T is its bi-specific approach, in that it is able to target more than one antigen to prevent tumor escape. OncoSec has several catalysts approaching in the 2nd half of 2019, the two most notable being the pre-FDA meeting for TAVO in metastatic melanoma and results from KEYNOTE-890. The company had about $34.1 million in cash as of May 28, 2019 but a recent proxy SEC filing of wanting to increase the amount of authorized shares, leads me to believe that further dilution can possibly be expected towards the end of this year. ONCS announced that it had licensed CAR-T cell therapy Potential Game Changing CAR-T Technology OncoSec had entered into a licensing agreement with Dana-Farber Cancer Institute. Spe
Show less
Read more
Impact Snapshot
Event Time:
ONCS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ONCS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ONCS alerts
High impacting OncoSec Medical Incorporated news events
Weekly update
A roundup of the hottest topics